New Ultrasound-Guided IV could spare newborns painful needle sticks
NCT ID NCT07568171
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study compares two types of IV catheters in 104 newborns with congenital syphilis who need 10 days of antibiotics. One group gets a standard short catheter, the other a longer catheter placed using ultrasound by a specialized nurse. The goal is to see which lasts longer and causes fewer problems, aiming to reduce painful re-sticks.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Ultrasound-guided long peripheral intravenous catheter
- What this could lead to
- If successful, this could mean fewer painful needle sticks and more reliable IV access for newborns with congenital syphilis.
- What could go wrong
- This is a small, early-stage trial with only 104 participants, so results may not apply broadly. The procedure requires specialized training and equipment.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 104 people
The number the study aims to enrol. It can still change while the study runs.
- Expected to start
-
May 2026
An estimate. Start dates often move.
- Expected to finish
-
Dec 2028
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
1 day to 28 days
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Newborns admitted to the Neonatal Intermediate Care Unit; * Diagnosis of congenital syphilis; * Indication for intravenous penicillin therapy for an estimated duration of 10 days; * Enrollment on the first day of treatment. Exclusion Criteria: * Newborns who have received any type of peripheral venous catheter prior to study enrollment; * Clinical instability at the time of vascular access indication and/or requirement for admission to a Neonatal Intensive Care Unit; * Requirement for concomitant administration of another antimicrobial agent in addition to crystalline penicillin; * Need for catheter insertion outside the operating hours of the Vascular Access Program (7:00 AM to 7:00 PM, Monday to Friday).
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Advanced practice nursing are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a simple rubric catch harmful medical advice?
- Ultrasound of calf muscles could reveal who is at risk of falling after stroke
- Can a battery keep ventilators running during ambulance transport?
- A global effort to make moving critically ill patients safer
- Can ultrasound spot early joint wear in diabetic nerve damage?
- AI reads heart ultrasound at the bedside: a test for faster detection of weak heart pumping